Jiang Chang Selected Research

Silicates

6/2022	Multi-functional wound dressings based on silicate bioactive materials.
10/2021	Ion therapy of pulmonary fibrosis by inhalation of ionic solution derived from silicate bioceramics.
1/2019	Silicate bioceramics: from soft tissue regeneration to tumor therapy.
4/2018	The clinical application of a silicate-based wound dressing (DermFactor®) for wound healing after anal surgery: A randomized study.
1/2018	Regulation of immune response by bioactive ions released from silicate bioceramics for bone regeneration.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jiang Chang Research Topics

Disease

64	Neoplasms (Cancer) 01/2022 - 09/2010
24	Wounds and Injuries (Trauma) 06/2022 - 11/2012
13	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 01/2016
13	Infections 12/2021 - 01/2012
10	Hypoxia (Hypoxemia) 09/2018 - 03/2012
9	Inflammation (Inflammations) 01/2021 - 11/2011
7	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022 - 01/2016
6	Adenocarcinoma 01/2022 - 03/2012
6	Heart Failure 01/2022 - 07/2003
6	Neoplasm Metastasis (Metastasis) 01/2022 - 12/2015
6	Carcinogenesis 01/2021 - 01/2016
6	Esophageal Squamous Cell Carcinoma 10/2020 - 09/2015
5	Breast Neoplasms (Breast Cancer) 03/2022 - 12/2016
5	Stomach Neoplasms (Stomach Cancer) 01/2022 - 04/2012
5	Hepatocellular Carcinoma (Hepatoma) 11/2021 - 01/2013
5	Cardiomyopathies (Cardiomyopathy) 01/2020 - 09/2006
5	Lung Neoplasms (Lung Cancer) 04/2016 - 01/2014
4	Residual Neoplasm 12/2021 - 05/2016
4	Melanoma (Melanoma, Malignant) 10/2021 - 01/2018
4	Fibrosis (Cirrhosis) 10/2021 - 05/2006
4	Cicatrix (Scar) 01/2021 - 01/2013
4	Bone Resorption 07/2019 - 02/2011
4	Weight Loss (Weight Reduction) 08/2009 - 01/2006
3	COVID-19 12/2021 - 06/2020
3	Burns 07/2021 - 01/2020
3	Myocardial Infarction 01/2020 - 01/2019
3	T-Cell Lymphoma (Lymphoma, T Cell) 05/2014 - 04/2012
2	Klatskin Tumor 01/2022 - 10/2020
2	Heart Diseases (Heart Disease) 01/2022 - 05/2012
2	Genomic Instability 12/2021 - 01/2021
2	Sepsis (Septicemia) 01/2021 - 05/2014
2	Osteosarcoma (Osteogenic Sarcoma) 01/2020 - 06/2013
2	Lymphoma (Lymphomas) 07/2019 - 01/2017
2	Skin Neoplasms (Skin Cancer) 01/2019 - 01/2018
2	Genetic Predisposition to Disease (Genetic Predisposition) 01/2018 - 02/2016
2	Hyperthermia 05/2016 - 10/2011
2	Tympanic Membrane Perforation 03/2016 - 01/2016
2	Non-alcoholic Fatty Liver Disease 01/2016 - 01/2013

Drug/Important Bio-Agent (IBA)

18	IonsIBA 12/2021 - 03/2012
13	Proteins (Proteins, Gene)FDA Link 01/2022 - 07/2003
13	Biocompatible Materials (Biomaterials)IBA 12/2020 - 11/2013
10	Biological ProductsIBA 03/2022 - 04/2012
10	HydrogelsIBA 12/2021 - 12/2015
9	Pharmaceutical PreparationsIBA 01/2022 - 09/2010
9	Biomarkers (Surrogate Marker)IBA 10/2021 - 04/2012
8	MicroRNAs (MicroRNA)IBA 01/2022 - 08/2011
7	Messenger RNA (mRNA)IBA 01/2022 - 01/2013
6	CollagenIBA 07/2020 - 01/2016
5	SilicatesIBA 06/2022 - 01/2018
5	Transcription Factors (Transcription Factor)IBA 03/2022 - 07/2003
5	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 01/2014
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2018 - 01/2013
4	Long Noncoding RNAIBA 01/2022 - 01/2016
4	AlginatesIBA 12/2021 - 12/2015
4	Therapeutic UsesIBA 10/2021 - 11/2013
4	StrontiumIBA 01/2021 - 02/2011
4	CytokinesIBA 01/2021 - 05/2006
4	ORALIT (ORS)IBA 01/2018 - 01/2013
3	RNA (Ribonucleic Acid)IBA 01/2022 - 10/2020
3	Anti-Bacterial Agents (Antibiotics)IBA 12/2021 - 01/2020
3	ChromatinIBA 10/2021 - 12/2016
3	poly(lactide) (polylactic acid)IBA 07/2021 - 09/2010
3	N-methyladenosineIBA 01/2021 - 10/2020
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 09/2018 - 11/2014
3	Caspase 3 (Caspase-3)IBA 01/2016 - 07/2003
2	Fatty Acids (Saturated Fatty Acids)IBA 01/2022 - 01/2020
2	6-propylchromone-2-carboxylic acid (PCCA)IBA 01/2022 - 10/2020
2	bisphenol AIBA 01/2022 - 10/2021
2	EnzymesIBA 01/2022 - 01/2015
2	Immunotoxins (Immunotoxin)IBA 01/2022 - 06/2018
2	GastrinsIBA 01/2022 - 09/2020
2	SolutionsIBA 10/2021 - 08/2009
2	calcium silicate (Wollastonite)IBA 10/2021 - 01/2019
2	6-methyladenineIBA 01/2021 - 10/2020
2	Colistin (Coly-Mycin)FDA Link 08/2020 - 01/2020
2	Carbapenems (Carbapenem Antibiotics)IBA 08/2020 - 01/2020
2	micaIBA 01/2020 - 10/2019
2	ElementsIBA 01/2020 - 07/2019
2	Metal-Organic FrameworksIBA 01/2020 - 01/2018
2	Genetic Markers (Genetic Marker)IBA 01/2020 - 10/2014
2	tetracarboxyphenylporphineIBA 01/2020 - 01/2018
2	CholesterolIBA 10/2019 - 01/2013
2	Protein Isoforms (Isoforms)IBA 01/2019 - 01/2019
2	Oxygen (Dioxygen)IBA 01/2019 - 03/2012
2	graphene oxideIBA 01/2019 - 05/2016
2	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2019 - 01/2018
2	copper silicateIBA 12/2018 - 01/2018
2	Prolyl Hydroxylases (Prolyl Hydroxylase)IBA 05/2018 - 11/2013
2	LuciferasesIBA 01/2016 - 05/2014
2	CobaltIBA 09/2015 - 03/2012

Therapy/Procedure

35	Therapeutics 01/2022 - 11/2012
8	Drug Therapy (Chemotherapy) 01/2022 - 12/2010
6	Photothermal Therapy 01/2020 - 01/2018
3	Lasers (Laser) 01/2019 - 01/2019
2	Transplantation 01/2022 - 07/2003
2	Immunotherapy 01/2021 - 01/2021
2	Photochemotherapy (Photodynamic Therapy) 01/2019 - 01/2018
2	Microspheres (Microsphere) 12/2018 - 01/2018
2	Induced Hyperthermia (Thermotherapy) 01/2018 - 10/2011
2	Radiotherapy 09/2015 - 05/2013